An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system

Katharina G. Wandera, Scott P. Collins, Franziska Wimmer, Ryan Marshall, Vincent Noireaux, Chase L. Beisel

Research output: Contribution to journalArticle

Abstract

The characterization of CRISPR-Cas immune systems in bacteria was quickly followed by the discovery of anti-CRISPR proteins (Acrs) in bacteriophages. These proteins block different steps of CRISPR-based immunity and, as some inhibit Cas nucleases, can offer tight control over CRISPR technologies. While Acrs have been identified against a few CRISPR-Cas systems, likely many more await discovery and application. Here, we report a rapid and scalable method for characterizing putative Acrs against Cas nucleases using an E. coli-derived cell-free transcription-translation system. Using known Acrs against type II Cas9 nucleases as models, we demonstrate how the method can be used to measure the inhibitory activity of individual Acrs in under two days. We also show how the method can overcome non-specific inhibition of gene expression observed for some Acrs. In total, the method should accelerate the interrogation and application of Acrs as CRISPR-Cas inhibitors.

Original languageEnglish (US)
JournalMethods
DOIs
StatePublished - Jan 1 2019

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Transcription
Assays
Proteins
CRISPR-Cas Systems
Bacteriophages
Immune system
Immune System
Immunity
Gene expression

Keywords

  • Anti-CRISPR proteins
  • Cas9
  • Genome editing
  • TXTL
  • sgRNA

PubMed: MeSH publication types

  • Journal Article

Cite this

An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system. / Wandera, Katharina G.; Collins, Scott P.; Wimmer, Franziska; Marshall, Ryan; Noireaux, Vincent; Beisel, Chase L.

In: Methods, 01.01.2019.

Research output: Contribution to journalArticle

Wandera, Katharina G. ; Collins, Scott P. ; Wimmer, Franziska ; Marshall, Ryan ; Noireaux, Vincent ; Beisel, Chase L. / An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system. In: Methods. 2019.
@article{47a8dfe9cd8d4fc69f9e39f2ae4be19b,
title = "An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system",
abstract = "The characterization of CRISPR-Cas immune systems in bacteria was quickly followed by the discovery of anti-CRISPR proteins (Acrs) in bacteriophages. These proteins block different steps of CRISPR-based immunity and, as some inhibit Cas nucleases, can offer tight control over CRISPR technologies. While Acrs have been identified against a few CRISPR-Cas systems, likely many more await discovery and application. Here, we report a rapid and scalable method for characterizing putative Acrs against Cas nucleases using an E. coli-derived cell-free transcription-translation system. Using known Acrs against type II Cas9 nucleases as models, we demonstrate how the method can be used to measure the inhibitory activity of individual Acrs in under two days. We also show how the method can overcome non-specific inhibition of gene expression observed for some Acrs. In total, the method should accelerate the interrogation and application of Acrs as CRISPR-Cas inhibitors.",
keywords = "Anti-CRISPR proteins, Cas9, Genome editing, TXTL, sgRNA",
author = "Wandera, {Katharina G.} and Collins, {Scott P.} and Franziska Wimmer and Ryan Marshall and Vincent Noireaux and Beisel, {Chase L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ymeth.2019.05.014",
language = "English (US)",
journal = "ImmunoMethods",
issn = "1046-2023",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - An enhanced assay to characterize anti-CRISPR proteins using a cell-free transcription-translation system

AU - Wandera, Katharina G.

AU - Collins, Scott P.

AU - Wimmer, Franziska

AU - Marshall, Ryan

AU - Noireaux, Vincent

AU - Beisel, Chase L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The characterization of CRISPR-Cas immune systems in bacteria was quickly followed by the discovery of anti-CRISPR proteins (Acrs) in bacteriophages. These proteins block different steps of CRISPR-based immunity and, as some inhibit Cas nucleases, can offer tight control over CRISPR technologies. While Acrs have been identified against a few CRISPR-Cas systems, likely many more await discovery and application. Here, we report a rapid and scalable method for characterizing putative Acrs against Cas nucleases using an E. coli-derived cell-free transcription-translation system. Using known Acrs against type II Cas9 nucleases as models, we demonstrate how the method can be used to measure the inhibitory activity of individual Acrs in under two days. We also show how the method can overcome non-specific inhibition of gene expression observed for some Acrs. In total, the method should accelerate the interrogation and application of Acrs as CRISPR-Cas inhibitors.

AB - The characterization of CRISPR-Cas immune systems in bacteria was quickly followed by the discovery of anti-CRISPR proteins (Acrs) in bacteriophages. These proteins block different steps of CRISPR-based immunity and, as some inhibit Cas nucleases, can offer tight control over CRISPR technologies. While Acrs have been identified against a few CRISPR-Cas systems, likely many more await discovery and application. Here, we report a rapid and scalable method for characterizing putative Acrs against Cas nucleases using an E. coli-derived cell-free transcription-translation system. Using known Acrs against type II Cas9 nucleases as models, we demonstrate how the method can be used to measure the inhibitory activity of individual Acrs in under two days. We also show how the method can overcome non-specific inhibition of gene expression observed for some Acrs. In total, the method should accelerate the interrogation and application of Acrs as CRISPR-Cas inhibitors.

KW - Anti-CRISPR proteins

KW - Cas9

KW - Genome editing

KW - TXTL

KW - sgRNA

UR - http://www.scopus.com/inward/record.url?scp=85066263736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066263736&partnerID=8YFLogxK

U2 - 10.1016/j.ymeth.2019.05.014

DO - 10.1016/j.ymeth.2019.05.014

M3 - Article

C2 - 31121300

AN - SCOPUS:85066263736

JO - ImmunoMethods

JF - ImmunoMethods

SN - 1046-2023

ER -